Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats
Ranirestat (AS-3201) is a novel aldose reductase (AR) inhibitor with potentially beneficial effects on diabetic sensorimotor polyneuropathy. In this study, we performed a kinetic analysis to determine the mode of inhibition of ranirestat on AR and investigated the effects of ranirestat on sorbitol l...
Saved in:
Main Authors: | Takafumi Matsumoto (Author), Yoshiyuki Ono (Author), Masuo Kurono (Author), Akemi Kuromiya (Author), Keiji Nakamura (Author), Vera Bril (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2008-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats
by: Takafumi Matsumoto, et al.
Published: (2008) -
Improvement of Motor Nerve Conduction Velocity in Diabetic Rats Requires Normalization of the Polyol Pathway Metabolites Flux
by: Takafumi Matsumoto, et al.
Published: (2009) -
Carica papaya Linn. fruit extract inhibited the activities of aldose reductase and sorbitol dehydrogenase: possible mechanism for amelioration of diabetic complications
by: Mutiu Idowu Kazeem, et al.
Published: (2020) -
Antidiabetic and aldose reductase inhibitory potentials of Land caltrops aqueous extract in streptozotocin-nicotinamide induced diabetic rats
by: Bheemesh Vangalapati, et al.
Published: (2020) -
Aldose reductase, oxidative stress and diabetic mellitus
by: Waiho eTang, et al.
Published: (2012)